Evidence map›Paper›PMID 36061308›Full record

ArticleJournal of immunology research2022

CIRBP Regulates Pancreatic Cancer Cell Ferroptosis and Growth by Directly Binding to p53.

Hongqiang Gao, Ran Xie, Rong Huang, Chonglin Wang, Yue Wang, Dongdong Wang, Kaimin Liu, Conghui Yang, Qingxiong Yang, Long Chen

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Important molecular mechanisms in ferroptosis.Molecular and cellular biochemistry · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Hongqiang GaoDepartment of Hepatobiliary Surgery, The First People's Hospital of Kunming City & Ganmei Affiliated Hospital of Kunming Medical University, No. 504 Youth Road, Kunming 650000, China.
Ran XieDepartment of PET/CT Center, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Yunnan, China.
Rong HuangDepartment of PET/CT Center, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Yunnan, China.
Chonglin WangDepartment of Hepatobiliary Surgery, The First People's Hospital of Kunming City & Ganmei Affiliated Hospital of Kunming Medical University, No. 504 Youth Road, Kunming 650000, China.
Yue WangDepartment of PET/CT Center, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Yunnan, China.
Dongdong WangDepartment of Hepatobiliary Surgery, The First People's Hospital of Kunming City & Ganmei Affiliated Hospital of Kunming Medical University, No. 504 Youth Road, Kunming 650000, China.
Kaimin LiuDepartment of Hepatobiliary Surgery, The First People's Hospital of Kunming City & Ganmei Affiliated Hospital of Kunming Medical University, No. 504 Youth Road, Kunming 650000, China.
Conghui YangDepartment of PET/CT Center, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Yunnan, China.
Qingxiong YangDepartment of Radiology, Kunming Children's Hospital, Yunnan, China.ORCID https://orcid.org/0000-0002-8404-5614
Long ChenDepartment of PET/CT Center, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Yunnan, China.ORCID https://orcid.org/0000-0001-8677-803X
Kunming Medical University · CNKunming Children's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pancreatic cancer is one of the most malignant gastrointestinal tumors, and it is of great significance to explore the molecular mechanism of its progression and find new biological therapeutic targets. CIRBP is a cold-induced protein that plays a key role in many physiological and pathological processes, but its role in pancreatic cancer is still unclear. The expression of CIRBP in pancreatic cancer tissues was slightly lower than that in normal tissues, and the high expression of CIRBP was beneficial to survival. At the same time, immunohistochemical detection showed that the expression level of CIRBP in the cytoplasm of cancer tissues was significantly lower than that of adjacent tissues; survival curve analysis showed that pancreatic cancer patients with high nuclear CIRBP expression had a longer overall survival period. RIP results showed that CIRBP antibody significantly enriched p53 RNA, indicating that it could directly bind to p53. Cold treatment of pancreatic cancer cells significantly induced the expression of CIRBP, DPP4, NOX1, and FTH1 and inhibited the expression of p53 and GPX4. Cold induction enhanced the accumulation of Fe

Indexed as

FerroptosisPancreatic NeoplasmsRNA-Binding ProteinsTumor Suppressor Protein p53Cell ProliferationHumansCIRBP protein, humanRNA-Binding ProteinsTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID36061308
PMCPMC9436628
OpenAlexW4293095399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.